Intervention Protocol

Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults

  1. Herbert Wong1,*,
  2. Aaron M Tejani2

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 18 APR 2012

DOI: 10.1002/14651858.CD006844.pub2


How to Cite

Wong H, Tejani AM. Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006844. DOI: 10.1002/14651858.CD006844.pub2.

Author Information

  1. 1

    Lower Mainland Pharmacy Services, Pharmacy, Surrey, BC, Canada

  2. 2

    University of British Columbia, Therapeutics Initiative, Vancouver, BC, Canada

*Herbert Wong, Pharmacy, Lower Mainland Pharmacy Services, 13750 96th Avenue, Surrey, BC, V3V 1Z2, Canada. herbertc.wong@fraserhealth.ca.

Publication History

  1. Publication Status: Amended to reflect a change in scope (see 'What's new')
  2. Published Online: 18 APR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To assess the effect that NK-1 receptor antagonists have on the quality of life of patients treated with highly emetogenic chemotherapy.
  • To assess the clinical efficacy of NK-1 receptor antagonists compared to standard antiemetic therapy in controlling emesis and nausea in participants on highly emetogenic chemotherapy.
  • To determine the adverse events associated with NK-1 receptor antagonists in participants receiving these drugs.